
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Standardised quantitative assays for anti-SARS-CoV-2 immune response used in vaccine clinical trials by the CEPI Centralized Laboratory Network: a qualification analysis
Mark Manak, Luc Gagnon, Steven Phay-Tran, et al.
The Lancet Microbe (2024) Vol. 5, Iss. 3, pp. e216-e225
Open Access | Times Cited: 9
Mark Manak, Luc Gagnon, Steven Phay-Tran, et al.
The Lancet Microbe (2024) Vol. 5, Iss. 3, pp. e216-e225
Open Access | Times Cited: 9
Showing 9 citing articles:
Preparedness and priority research to tackle the mpox outbreak response
Ali Azizi, Kristine Rose, Gathoni Kamuyu, et al.
Nature Medicine (2025)
Closed Access | Times Cited: 1
Ali Azizi, Kristine Rose, Gathoni Kamuyu, et al.
Nature Medicine (2025)
Closed Access | Times Cited: 1
Monitoring immunological COVID-19 vaccine clinical testing across the CEPI Centralized Laboratory Network
Lauren M. Schwartz, Jose Vila-Belda, Jerome Carless, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Lauren M. Schwartz, Jose Vila-Belda, Jerome Carless, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Driving consistency: CEPI-Centralized Laboratory Network’s conversion factor initiative for SARS-CoV-2 clinical assays used for efficacy assessment of COVID vaccines
Ali Azizi, Gathoni Kamuyu, Deborah Ogbeni, et al.
Human Vaccines & Immunotherapeutics (2024) Vol. 20, Iss. 1
Open Access | Times Cited: 3
Ali Azizi, Gathoni Kamuyu, Deborah Ogbeni, et al.
Human Vaccines & Immunotherapeutics (2024) Vol. 20, Iss. 1
Open Access | Times Cited: 3
Standardized immunological assays for assessing COVID-19 vaccines by the CEPI-Centralized Laboratory Network
Ali Azizi, Deborah Ogbeni, Gathoni Kamuyu, et al.
npj Vaccines (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 3
Ali Azizi, Deborah Ogbeni, Gathoni Kamuyu, et al.
npj Vaccines (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 3
Unifying global efforts by CEPI’s centralized laboratory network
Ali Azizi, Valentina Bernasconi
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 2
Ali Azizi, Valentina Bernasconi
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 2
Optimisation of a multiplexed, high throughput assay to measure neutralising antibodies against SARS-CoV-2 variants.
Caroline L. Ashley, Malik Bloul, Sibel Alca, et al.
Journal of Virological Methods (2024) Vol. 332, pp. 115073-115073
Open Access | Times Cited: 1
Caroline L. Ashley, Malik Bloul, Sibel Alca, et al.
Journal of Virological Methods (2024) Vol. 332, pp. 115073-115073
Open Access | Times Cited: 1
Optimisation of a multiplexed, high throughput assay to measure neutralising antibodies against SARS-CoV-2 variants.
Caroline L. Ashley, Malik Bloul, Sibel Alca, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Caroline L. Ashley, Malik Bloul, Sibel Alca, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Detection of Neutralizing Antibodies in Serum Samples Using a SARS‐CoV‐2 Pseudotyped Virus Assay
Sol Ferrero, María Victoria Batto, Matías Gatto, et al.
Current Protocols (2024) Vol. 4, Iss. 10
Closed Access
Sol Ferrero, María Victoria Batto, Matías Gatto, et al.
Current Protocols (2024) Vol. 4, Iss. 10
Closed Access
Validation of an interferon-gamma enzyme-linked immunosorbent spot assay to evaluate cell-mediated immunity against severe acute respiratory syndrome coronavirus 2
Yunhwa Kim, Eun-Jeong Jang, Ji Young Hwang, et al.
Human Vaccines & Immunotherapeutics (2024) Vol. 20, Iss. 1
Open Access
Yunhwa Kim, Eun-Jeong Jang, Ji Young Hwang, et al.
Human Vaccines & Immunotherapeutics (2024) Vol. 20, Iss. 1
Open Access